The development of immunotherapies against leukaemia could be improved if T cells are activated moderately, not excessively, results from a German study have suggested.
In a mouse model, scientists from the German Cancer Resear...
13 days ago
Promising results have been seen in two clinical trials of chimeric antigen receptor T (CAR-T) cells targeting the CD19 antigen, for patients with leukaemia and lymphoma. The trials demonstrated that manufacturing CAR-T cells l...
13 days ago